Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neurologix Inc.

www.neurologix.net

Latest From Neurologix Inc.

Deal Watch, M&A: Warp Drive And Its Partnerships Acquired By Revolution

Once expected to be absorbed by Sanofi, US biotech Warp Drive Bio now will become part of California’s Revolution Medicines in a stock transaction. Sosei elects against its option to acquire MiNA Therapeutics; MeiraGTX follows its June IPO with takeout of Vector Neurosciences. Other recent mergers and acquisitions... 

M & A Deals

Reinventing Cell Therapy And Biomaterials

A profound redefinition of the role of many cell types and biomaterials in regenerative medicine is under way as researchers have moved away from the notion that cells introduced into the body will integrate and become functioning tissue.

Medical Device BioPharmaceutical

The Unlikely Renaissance Of Gene Therapy

After a decade of doubts, fears, and scares, advances in gene therapy have brought one drug close to approval, and a few venture-backed start-ups are gaining momentum. Is it enough to persuade more VCs to jump in?

BioPharmaceutical United States

Concerns about PhII Parkinson gene therapy sends Neurologix into bankruptcy

Neurologix Inc. filed for voluntary Chapter 7 bankruptcy protection in US Bankruptcy Court for the District of Delaware on 16 March to liquidate assets after it spent the past year looking for financing or a partner to advance its Parkinson's disease gene therapy into Phase III clinical trials.

Neurology
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Neurologix Inc.
  • Senior Management
  • Marc L Panoff, CFO, Treasurer & Secretary
    Christine V Sapan, PhD, EVP & Chief Dev. Officer
    Andrew I Koven, Pres. & Chief Admin. Officer
  • Contact Info
  • Neurologix Inc.
    Phone: (201) 592-6451
    One Bridge Plaza
    Fort Lee, NJ 07024
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register